30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Patrick Christmas

Track

Insider profile

Currently holds a position at Amag Pharma Usa Inc

Positions

Position Company Period
Vice President, General Counsel Amag Pharma Usa Inc June 1, 2011 -
Senior Vice President, General Counsel Regenxbio Inc Aug. 1, 2016 - Dec. 31, 2019
Patrick Christmas's trades of Regenxbio Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-02-17 2021-02-12
US Regenxbio Inc (RGNX)
PlS Planned sale
56,420 -9.4%
285.39
US$2,604,380 		56,420 -9.4% 285.39 US$2,604,380
2021-02-10 2021-02-08
US Regenxbio Inc (RGNX)
PlS Planned sale
42,531 +43.2%
35.59
US$939,659 		42,531 +43.2% 35.59 US$939,659
2021-02-04 2021-02-02
US Regenxbio Inc (RGNX)
PlS Planned sale
98,063 -37.4%
496.44
US$334,890 		98,063 -37.4% 496.44 US$334,890
2021-02-04 2021-02-02
US Regenxbio Inc (RGNX)
PlS Planned sale
9,500 -36.0%
44.77
US$425,315 		9,500 -36.0% 44.77 US$425,315
2021-01-12 2021-01-12
US Regenxbio Inc (RGNX)
PlS Planned sale
1,378 -7.8%
49.15
US$67,729 		1,378 -7.8% 49.15 US$67,729
2021-01-12 2021-01-11
US Regenxbio Inc (RGNX)
PlS Planned sale
10,122 -38.2%
49.08
US$496,788 		10,122 -38.2% 49.08 US$496,788
2021-01-12 2021-01-08
US Regenxbio Inc (RGNX)
PlS Planned sale
1,320 -7.5%
48.13
US$63,532 		1,320 -7.5% 48.13 US$63,532
2021-01-12 2021-01-08
US Regenxbio Inc (RGNX)
PlS Planned sale
4,062 -18.7%
47.42
US$192,620 		4,062 -18.7% 47.42 US$192,620
2021-01-12 2021-01-08
US Regenxbio Inc (RGNX)
PlS Planned sale
4,618 -17.5%
46.43
US$214,414 		4,618 -17.5% 46.43 US$214,414
2019-09-16 2019-09-12
US Regenxbio Inc (RGNX)
PlS Planned sale
5,486 -68.1%
42.00
US$230,412 		5,486 -68.1% 42.00 US$230,412
2019-07-22 2019-07-19
US Regenxbio Inc (RGNX)
PlS Planned sale
4,900 -61.6%
50.03
US$245,147 		4,900 -61.6% 50.03 US$245,147
2019-07-22 2019-07-18
US Regenxbio Inc (RGNX)
PlS Planned sale
100 -3.2%
50.00
US$5,000 		100 -3.2% 50.00 US$5,000
2019-06-20 2019-06-18
US Regenxbio Inc (RGNX)
PlS Planned sale
100 -3.2%
54.75
US$5,475 		100 -3.2% 54.75 US$5,475
2019-06-20 2019-06-18
US Regenxbio Inc (RGNX)
PlS Planned sale
1,934 -38.4%
53.29
US$103,063 		1,934 -38.4% 53.29 US$103,063
2019-06-20 2019-06-18
US Regenxbio Inc (RGNX)
PlS Planned sale
2,966 -37.0%
52.74
US$156,427 		2,966 -37.0% 52.74 US$156,427
2019-04-22 2019-04-18
US Regenxbio Inc (RGNX)
PlS Planned sale
100 -3.2%
55.50
US$5,550 		100 -3.2% 55.50 US$5,550
2019-04-22 2019-04-18
US Regenxbio Inc (RGNX)
PlS Planned sale
885 -22.2%
54.66
US$48,374 		885 -22.2% 54.66 US$48,374
2019-04-22 2019-04-18
US Regenxbio Inc (RGNX)
PlS Planned sale
1,115 -21.8%
53.67
US$59,842 		1,115 -21.8% 53.67 US$59,842
2019-04-22 2019-04-18
US Regenxbio Inc (RGNX)
PlS Planned sale
2,900 -36.2%
52.55
US$152,395 		2,900 -36.2% 52.55 US$152,395